FDA Approved: BUPROPION — Supplemental Application (Zydus Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for Bupropion from Zydus Pharmaceuticals USA Inc., indicating an approved update to an existing Bupropion product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Nicotine Dependence
• Seasonal Affective Disorder

Drugs mentioned

• bupropion (bupropion)

Snippet

SUPPL AP for BUPROPION (BUPROPION)